IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.

IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.
复制标题

使用骨髓细胞作为传递系统将 IFN-β 基因转移到中枢神经系统。

DOI:
10.1089/107999002320271378
复制
发表时间:
2002
期刊:
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
影响因子:
--
通讯作者:
Dhib-Jalbut,Suhayl
Dhib-Jalbut,Suhayl
中科院分区:
--
文献类型:
--
作者:
Makar,TapasKumar;Wilt,Susan;Dong,Zhongyun;Fishman,Paul;Mouradian,MMaral;Dhib-Jalbut,Suhayl

文献摘要

被引文献

相似文献

由于血脑屏障的存在,干扰素-β(干扰素-β)外周给药治疗中枢神经系统疾病仅有部分疗效。为了避免这个问题,我们评估了通过基因改变骨髓细胞性活体并将其作为载体将干扰素-β基因转移到小鼠中枢神经系统的可行性。用干扰素β逆转录病毒表达载体(pLXSN-干扰素β)稳定转染PA317细胞。用表达干扰素-β基因和蛋白的分泌细胞上清液感染骨髓细胞。当移植到受照射的小鼠体内时,干扰素-β工程的骨髓细胞进入中枢神经系统,并表达干扰素-β的基因和蛋白。用对照新霉素载体转导的骨髓细胞进入大脑,表达新霉素,但不表达干扰素-β基因。在中枢神经系统中,骨髓细胞递送的干扰素-β诱导2‘,5’-寡腺苷合成酶(2‘,5’-OAS)的基因表达,表明其具有生物学活性。我们的研究结果表明,骨髓细胞可以作为干扰素-β基因进入中枢神经系统的输送系统,这可能对多发性硬化症(MS)、病毒性脑炎和脑肿瘤等神经系统疾病的治疗具有指导意义。
The peripheral delivery of interferon-β(IFN-β) for the treatment of central nervous system (CNS) diseases is only partially effective because of the blood-brain barrier (BBB). To circumvent this problem, we evaluated the feasibility of genetically altering bone marrow cellsex vivoand using them as vehicles to transfer the IFN-βcDNA into the mouse CNS. An IFN-βretroviral expression vector (pLXSN-IFNβ) was used to stably transfect PA317 cells. The supernatant from these producer cells, which expressed IFN-βmRNA and protein, were used to infect bone marrow cells. When transplanted into irradiated mice, IFN-β-engineered marrow cells accessed the CNS and expressed IFN-βmRNA and protein. Marrow cells transduced with a control neomycin vector entered the brain and expressed the neomycin but not the IFN-βgene. In the CNS, IFN-βdelivered by marrow cells induced the mRNA expression of 2′,5′-oligoadenylate synthetase (2′,5′-OAS), indicating biologic activity. Our findings demonstrating that bone marrow cells can serve as a delivery system for IFN-βcDNA into the CNS could have implications for the treatment of neurologic disorders, such as multiple sclerosis (MS), viral encephalitis, and brain tumors.